X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share (XFOR)

Historical Holders from Q1 2025 to Q3 2025

Symbol
XFOR on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
22,465,656
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
13,652,105
Holdings value
$46,690,414
% of all portfolios
0.001%
Number of holders
40
Number of buys
20
Number of sells
-29
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share (XFOR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 14.8% $29,402,636 8,499,100 FMR LLC 31 Oct 2025
PERCEPTIVE ADVISORS LLC 7.6% $20,980,760 6,064,680 Perceptive Advisors LLC 27 Oct 2025
Growth Equity Opportunities 18 VGE, LLC 6.2% -37.9% $17,496,802 +$9,734,867 5,057,610 +1.3% Growth Equity Opportunities 18 VGE, LLC 27 Oct 2025
Empery Asset Management, LP 9.99% $8,642,391 2,498,162 Empery Asset Management, LP 30 Sep 2025
Coastlands Capital LP 9.99% 0% $7,773,911 +$37,418 2,491,638 +0.48% Coastlands Capital LP 03 Oct 2025
Bain Capital Life Sciences Fund, L.P. 9.99% 0% $7,139,203 +$182 2,436,588 +0% Bain Capital Life Sciences Fund, L.P. 09 Sep 2025
Deep Track Capital, LP 9.99% $4,568,300 2,366,995 Deep Track Capital, LP 12 Aug 2025
Trails Edge Capital Partners, LP 9.9% $4,472,105 2,317,153 Trails Edge Capital Partners, LP 11 Aug 2025
Nantahala Capital Management, LLC 9.99% $7,678,489 2,244,319 Nantahala Capital Management, LLC 30 Sep 2025
BIOTECHNOLOGY VALUE FUND L P 9.9% $4,330,262 2,243,659 BVF PARTNERS L P/IL 13 Aug 2025
BlackRock, Inc. 3% $377,954 179,125 BlackRock, Inc. 30 Jun 2025

Institutional Holders of X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share (XFOR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 13,652,105 $46,690,414 +$40,048,768 $3.42 40
2025 Q2 2,150,633 $4,086,190 +$4,064,925 $1.9 49
2025 Q1 83,045 $20,007 +$20,007 $0.2371 2